Validation of a Nutrition Screening Tool
NCT01851928 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128
Last updated 2013-05-13
Summary
The objective of this study is to evaluate the sensitivity and specificity of two nutrition screening tools to identify inpatients with malnutrition or at risk of malnutrition. The two tools are the Royal Marsden Abridged Adult Nutrition Screening Tool (AANST) and the Malnutrition Screening Tool (MST)\[10\] The tools will be compared with the currently accepted gold standard, Patient Generated Subjective Global Assessment (PG-SGA). Both screening tools are in the form of scored questionnaires and are suitable for electronic input.
The ultimate objective is to select an adult inpatient nutrition screening tool with the highest sensitivity for future use in the oncology inpatient setting in order to allow prompt commencement of an appropriate nutrition care plan.
Conditions
- Adenocarcinoma of the Gastroesophageal Junction
- Cervical Cancer
- Endometrial Cancer
- Esophageal Cancer
- Fallopian Tube Cancer
- Gastric Cancer
- Ovarian Cancer
- Sarcoma
- Vaginal Cancer
- Vulvar Cancer
Sponsors & Collaborators
-
Royal Marsden NHS Foundation Trust
lead OTHER
Principal Investigators
-
Clare Shaw, Phd · Royal Marsden Hospital NHS Foundation Trust
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-07-31
- Primary Completion
- 2012-09-30
- Completion
- 2013-03-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study
NCT02555358 ·Status: COMPLETED ·Phase: PHASE2
-
Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer
NCT02873520 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Drug Sensitivity Screening for Gastrointestinal Cancer
NCT04298489 ·Status: UNKNOWN ·Phase: NA
-
Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer
NCT05497739 ·Status: UNKNOWN ·Phase: PHASE2
-
An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer
NCT04745988 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
PTC in Personalizing Neoadjuvant Therapy for Patients With Advanced Gastrointestinal Tumor
NCT05280210 ·Status: UNKNOWN ·Phase: NA
-
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors
NCT01040312 ·Status: COMPLETED
-
A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis
NCT00149201 ·Status: COMPLETED ·Phase: PHASE3
-
Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC
NCT06684158 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE.
NCT00180973 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer
NCT01662869 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer
NCT07332533 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma
NCT02301481 ·Status: COMPLETED ·Phase: PHASE2
-
Home Parenteral Nutrition for Malnourished Unresectable Stage IV Gastric Cancer
NCT03121807 ·Status: COMPLETED ·Phase: NA
-
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
NCT05702229 ·Status: RECRUITING ·Phase: PHASE2
-
Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC
NCT03061058 ·Status: UNKNOWN ·Phase: PHASE3
-
Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma
NCT05237349 ·Status: RECRUITING ·Phase: PHASE2
-
The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical Study
NCT02583659 ·Status: UNKNOWN
-
Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
NCT03425058 ·Status: COMPLETED
-
The Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer
NCT06856382 ·Status: ACTIVE_NOT_RECRUITING
-
Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer
NCT02500043 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer.
NCT06385691 ·Status: RECRUITING ·Phase: PHASE2
-
Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study
NCT01558011 ·Status: TERMINATED ·Phase: PHASE2
-
Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.
NCT00209729 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method
NCT06100003 ·Status: RECRUITING